MyRNA Diagnostics is establishing Malaysia’s leading miRNA-based early cancer detection platform — localising globally validated technology to improve survival through earlier intervention.
A blood-based miRNA molecular screening test designed to identify individuals at elevated risk of gastric cancer and support earlier clinical intervention.
Learn More
A blood-based miRNA risk stratification test designed to identify individuals at increased risk of lung cancer and support earlier detection strategies.
Learn MoreWe collaborate with leading organizations to deliver exceptional solutions.
Stay informed with our latest articles, insights, and news.
At MyRNA Diagnostics, we believe that meaningful healthcare innovation happens when science, clinical expertise and industry come together with a shar...
The meeting served as a valuable platform for discussions on enhancing early disease detection and improving access to preventive healthcare services, in line with PERKESO's ongoing commitment to safeguarding the health and wellbeing of its members.
From 12–14 June 2026, MyRNA participated in the Malaysian Medical Association Congress (MMAC) 2026, held at the Royal Chulan Kuala Lumpur. Organi...
Let's discuss how we can help you achieve your goals with our innovative solutions.
Enquire About Partnership